From the source
LG AI Research and D&D Pharmatech signed a definitive agreement to jointly develop next-generation peptide therapeutics.
LG AI Research will design drug candidates using AI, while D&D Pharmatech will handle validation, clinical development, and regulatory approval.
The collaboration aims to reduce development timelines and costs while improving clinical success probability.






